Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,790
+110 (0.75%)
At close: Feb 20, 2026

KRX:271980 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
215,513166,115249,173306,279--
Market Cap Growth
27.39%-33.33%-18.64%---
Enterprise Value
291,550219,930307,855346,439--
Last Close Price
14790.0011400.0017100.0020937.6133666.1062145.11
PE Ratio
10.97-49.79---
PS Ratio
0.350.240.340.42--
PB Ratio
0.880.761.461.87--
P/TBV Ratio
1.100.911.621.99--
P/OCF Ratio
-51.70----
EV/Sales Ratio
0.470.310.420.48--
EV/EBITDA Ratio
8.37-16.50---
EV/EBIT Ratio
12.76-34.64---
Debt / Equity Ratio
0.380.350.420.330.290.29
Debt / EBITDA Ratio
2.67-3.82--2.30
Debt / FCF Ratio
----3.48-
Net Debt / Equity Ratio
0.150.080.210.140.120.25
Net Debt / EBITDA Ratio
1.06-2.511.90-5.12-15.871.99
Net Debt / FCF Ratio
-2.91-17.13-3.21-0.871.44-1.99
Asset Turnover
1.251.391.541.641.681.71
Inventory Turnover
3.844.925.195.615.155.53
Quick Ratio
0.820.790.660.710.780.75
Current Ratio
1.301.181.041.121.281.27
Return on Equity (ROE)
13.46%-15.45%3.11%-9.06%-8.82%4.08%
Return on Assets (ROA)
2.87%-2.29%1.18%-1.89%-1.55%1.92%
Return on Invested Capital (ROIC)
7.90%-8.36%4.52%-7.13%-5.16%3.42%
Return on Capital Employed (ROCE)
8.80%-7.90%4.90%-6.80%-5.10%6.50%
Earnings Yield
9.11%-18.04%2.01%-4.27%--
FCF Yield
-5.90%-0.64%-4.45%-8.57%--
Dividend Yield
--0.29%0.24%--
Payout Ratio
--14.55%--14.79%
Buyback Yield / Dilution
0.00%-0.02%0.23%0.04%0.41%
Total Shareholder Return
0.00%-0.31%0.47%0.04%0.41%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.